A gummy specification should define the decision—not just describe the product.
Use this buyer checklist to turn a gummy concept into version-controlled acceptance criteria for the formula, finished batch, packaging and release file before sample approval or commercial production. For load planning, use the formula-space calculator to separate the label target from source-material mass before drafting the acceptance table.
Three different things are often called “the spec”
A target states what the project is trying to achieve. An acceptance criterion defines what is approved and how conformity will be decided. An actual result records what was observed for an identified sample or batch. Keep the three separate so a proposal, specification and COA cannot be mistaken for one another.
Build a four-layer specification stack
Project and label basis
Legal entity, product name, target market, serving, ingredient declarations, package and revision.
Components and process
Component identity, ingredient forms, necessary limits and controlled in-process stages.
Finished product
Identity, purity, strength, composition, contaminant limits and approved physical attributes.
Package and release
Container, closure, label version, examination, sampling, record review and disposition.
Minimum fields for a controlled gummy specification
1. Document control
- Specification ID, revision and effective date
- Product/SKU and responsible legal entities
- Formula or master-record cross-reference
- Prepared, reviewed and approved by
- Superseded version and change reason
2. Market and label scope
- Destination country and sales channel
- Serving size and pieces per serving
- Supplement Facts and ingredient-list basis
- Dietary, allergen and customer requirements
- Approved package count and label version
3. Active and component identity
- Ingredient and chemical/botanical form
- Supplier or grade restrictions where applicable
- Declared amount and unit per serving
- Component identity approach
- Necessary purity, strength, composition and contaminant criteria
4. Finished-product criteria
- Identity, purity, strength and composition
- Applicable contaminant limits
- Piece weight, count and physical appearance
- Texture, flavor and coating criteria when contractually controlled
- Moisture, water activity, pH or other attributes only where justified and defined
5. Packaging and labeling
- Container, closure, liner, seal and desiccant where applicable
- Material, dimensions, fill/count and coding
- Label/artwork identifier and reconciliation controls
- Shipping configuration and storage conditions
- Container-closure link to stability evidence
6. Method and sampling
- Test or examination method/reference
- Matrix, analyte, unit and reporting convention
- Sample type, location, size and handling
- Lot/batch population and sampling basis
- Laboratory and method-appropriateness responsibility
7. Result and disposition
- Acceptance range, maximum/minimum or qualitative criterion
- Actual result and pass/fail decision
- Out-of-specification or deviation pathway
- Quality-control review and release/rejection
- Record IDs tying the result to the batch
8. Change and evidence boundary
- Formula, supplier, process, method and package change triggers
- Impact on label and market scope
- Impact on sampling/testing and stability
- Customer notification or approval requirement
- Public-disclosure rights for any resulting claim
Acceptance matrix: define each row before requesting a COA
| Specification row | Scope to define | Decision fields | Common mistake |
|---|---|---|---|
| Active identity and amount | Ingredient form, declared serving, product/batch | Criterion, unit, method, sample and result | Using raw-material assay as finished-gummy potency |
| Composition | Formula-relevant ingredients and declared composition | Controlled formula/version and verification basis | Assuming one tested analyte verifies the complete formula |
| Contaminants | Defined analytes/categories and applicable product/market | Limits, methods, units and sample | Writing “passes safety” without naming what was examined |
| Microbiological criteria | Finished product and applicable criteria | Organisms/counts, limits, method and result | Mixing limits or units from different specifications |
| Physical attributes | Approved piece, batch, package and sensory reference | Measurable range or controlled qualitative standard | Treating an unnumbered sample as the entire specification |
| Package and label | Container-closure and artwork revision | Identifiers, examinations and reconciliation | Approving the product while the commercial package remains undefined |
| Shelf-life support | Formula, package, conditions, dates and evidence stage | Time points, methods, criteria and approved wording | Using a release COA or another package as automatic shelf-life proof |
How finished-batch verification fits the specification
FDA's dietary supplement CGMP framework separates establishing specifications from determining whether they are met. It calls for specifications covering components, in-process production, the finished batch, labels and packaging, and the finished packaged and labeled product. Tests and examinations used to determine conformity must be appropriate and scientifically valid.
For finished batches, 21 CFR 111.75(c) describes verification for a subset of batches identified through a sound statistical sampling plan—or for every finished batch. Selected specifications and the documented basis must be sufficient to verify that the production and process-control system produces a supplement meeting all applicable product specifications, subject to the rule's documented exemption pathway. Quality-control personnel review and approve the basis. This is why “we test every batch” and “every specification is tested on every batch” are not interchangeable statements.
The batch production record then connects the specification to execution: it includes identifiers, components, yields, monitoring and test results, documentation that finished-product and packaging/labeling specifications are met, and the quality-control review and release or rejection decision.
Seven-step buyer workflow
- Lock the project basis. Identify the market, serving, ingredient forms, label direction and package before comparing specifications.
- Draft the acceptance matrix. Give every criterion a scope, method or examination approach, unit, sampling basis and owner.
- Separate legal/quality requirements from preferences. Mark sensory targets, retailer requirements and regulatory specifications distinctly.
- Review the sample against controlled criteria. Record the sample ID, formula version, differences and unresolved items, then use the sample-to-commercial transfer checklist to define scale-up decisions.
- Map criteria to manufacturing records. Identify which controls belong in component records, in-process monitoring, the master manufacturing record, batch record and release report.
- Approve changes before transfer. Assess formula, supplier, process, method, package and label changes instead of assuming the old approval carries forward. For bottle, closure, liner, desiccant, label or packaging-supplier changes, use the packaging change-control checklist.
- Close the release file. Match the commercial batch, tests, packaging and quality disposition before shipment or any public performance statement. Use the third-party laboratory report checklist to verify sample, method, unit and laboratory scope.
Copy-ready specification request
Use this as a non-confidential first request. Replace brackets with project facts and leave unknown items open rather than inventing values.
Connect the specification to the rest of supplier qualification
A specification is only one evidence layer. Use the COA and batch-records checklist to distinguish document types, the shelf-life evidence checklist for product-package-time support, the label and artwork approval checklist to reconcile formula, regulated content and released revisions, the packaging change-control checklist for old-to-new configuration review, the complaint and OOS checklist for failed-result or post-release response, and the project evidence register to separate internal review from public disclosure rights.
For Sucotond projects, the Brooklyn office can organize non-confidential specification questions for factory review. The turmeric page applies the fields to a botanical; the probiotic page connects strain and CFU timing; the mushroom page separates species, material and marker method; the omega-3 page separates source oil, EPA/DHA basis, oxidation method and package; and the inositol page separates myo-/D-chiro identity, individual amounts, ratio, matrix and method. None invents a formula or result. Availability of a method, result, record or commercial commitment depends on the product, formula, batch, target market and authorized document owner. A preliminary review is not a product approval or guarantee.
Gummy manufacturer RFQ template
Define the commercial and technical project inputs needed for comparable supplier responses.
Build the RFQ →24-point qualification checklist
Review legal entity, facility, product, batch, stability and commercial evidence in one matrix.
Open checklist →Frequently asked questions
Is a finished-product COA the same as a complete gummy product specification?
No. A product specification defines approved criteria, scope, methods or examination approach and disposition rules. A COA reports defined results for an identified sample or batch and should be evaluated against the applicable approved specification.
Must every finished gummy batch be tested for every product specification?
The dietary supplement CGMP rule requires verification of selected finished-product specifications for a statistically identified subset of finished batches, or every finished batch. The selected specifications, testing basis and any permitted exemption from finished-stage verification require documented justification and quality-control review.
Can an approved gummy sample replace written acceptance criteria?
No. A sample can help communicate sensory and physical expectations, but it should be identified and translated into controlled criteria where practical. It does not by itself define ingredient identity, active amount, contaminants, methods, packaging, shelf-life support or batch-release requirements.
Does FDA provide one universal set of numerical limits for every gummy supplement?
No single generic table replaces a product-specific assessment. Applicable criteria depend on the formula, ingredient forms, intended label, manufacturing process, package, target market and other legal or customer requirements.
When should a gummy specification be reviewed again?
Review is appropriate when the formula, component source, process, test method, package, label, intended market, serving design, shelf-life basis or other specification-relevant condition changes. The change should be assessed before assuming the previous approval still applies.
Official references and scope
This page translates U.S. dietary-supplement CGMP concepts into buyer questions. It is not a complete specification, quality agreement, legal opinion or regulatory approval. Qualified quality and regulatory personnel should determine the requirements that apply to the actual product and market.
Have a product brief but no controlled acceptance matrix?
Share the non-confidential formula, serving, package, market and required attributes. Our U.S. team will organize the open specification questions for factory review.
Request a Project Review